Correction to: Nature Medicine https://doi.org/10.1038/s41591-019-0628-7, published online 4 November 2019.
In the version of this article initially published, the labels in the key to Fig. 1f (red bars, Down in responders; blue bars, Up in responders) were incorrect. The correct labels are as follows: red bars, Up in responders; blue bars, Down in responders. Also, the histopathology images in Fig. 2a were incorrect. The correct images are now provided. The errors have been corrected in the HTML and PDF versions of the article.
Original and Corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Powles, T., Kockx, M., Rodriguez-Vida, A. et al. Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial. Nat Med 26, 983 (2020). https://doi.org/10.1038/s41591-020-0923-3
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41591-020-0923-3
